blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP1939290

EP1939290 - Gene expression control [Right-click to bookmark this link]
StatusThe application is deemed to be withdrawn
Status updated on  17.04.2015
Database last updated on 25.09.2024
Most recent event   Tooltip17.04.2015Application deemed to be withdrawnpublished on 20.05.2015  [2015/21]
Applicant(s)For all designated states
Centre National de la Recherche Scientifique
3, rue Michel-Ange
75016 Paris / FR
For all designated states
INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM)
101, rue de Tolbiac
75654 Paris Cédex 13 / FR
For all designated states
MUSEUM NATIONAL D'HISTOIRE NATURELLE
57, rue Cuvier
75005 Paris / FR
[N/P]
Former [2008/27]For all designated states
Centre National de la Recherche Scientifique
3, rue Michel Ange
75016 Paris / FR
For all designated states
INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM)
101, rue de Tolbiac
75654 Paris Cédex 13 / FR
For all designated states
MUSEUM NATIONAL D'HISTOIRE NATURELLE
57, rue Cuvier
75005 Paris / FR
Inventor(s)01 / Helene, Claude
14 quai d'Orléans
75004 Paris / FR
02 / Giovannangeli, Carine
16 rue Larrey
75005 Paris / FR
 [2008/27]
Representative(s)Dernoncour, Roxane
Aventis Pharma S.A.
20 Avenue Raymond Aron
92165 Antony Cedex / FR
[N/P]
Former [2008/27]Dernoncour, Roxane
AVENTIS PHARMA S.A. 20 Avenue Raymond Aron
92165 Antony Cedex / FR
Application number, filing date07007057.827.12.1994
[2008/27]
Priority number, dateFR1993001579829.12.1993         Original published format: FR 9315798
[2008/27]
Filing languageFR
Procedural languageFR
PublicationType: A2 Application without search report 
No.:EP1939290
Date:02.07.2008
Language:FR
[2008/27]
Type: A3 Search report 
No.:EP1939290
Date:06.07.2011
[2011/27]
Search report(s)(Supplementary) European search report - dispatched on:EP06.06.2011
ClassificationIPC:C12N15/113, A61K31/713, // C12N15/86
[2011/27]
CPC:
C12N15/113 (EP,US); A61P31/12 (EP); A61P31/22 (EP);
A61P35/00 (EP); C12N15/1132 (EP,US); C12N15/1136 (EP,US);
A61K38/00 (EP,US); C12N2310/152 (EP,US); C12N2310/53 (EP,US);
C12N2310/531 (EP,US); C12N2310/532 (EP,US); Y10S977/802 (EP,US);
Y10S977/916 (EP,US); Y10S977/92 (EP,US) (-)
Former IPC [2008/27]C12N15/11, A61K31/713
Designated contracting statesAT,   BE,   CH,   DE,   DK,   ES,   FR,   GB,   GR,   IE,   IT,   LI,   LU,   NL,   PT,   SE [2008/27]
TitleGerman:Steuerung der Expression von Genen[2008/27]
English:Gene expression control[2008/27]
French:Contrôle de l'expression de gènes[2008/27]
Examination procedure09.01.2012Examination requested  [2012/08]
12.04.2012Amendment by applicant (claims and/or description)
02.06.2014Despatch of a communication from the examining division (Time limit: M06)
13.12.2014Application deemed to be withdrawn, date of legal effect  [2015/21]
13.01.2015Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time  [2015/21]
Parent application(s)   TooltipEP95905172.3  / EP0737248
Divisional application(s)The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued (EP19950905172) is  04.05.2004
Request for further processing for:The application is deemed to be withdrawn due to failure to reply to the Extended European Search Report/Written Opinion of the International Searching Authority/International Preliminary Examination Report/Supplementary international search report/Supplementary European search report
12.04.2012Request for further processing filed
12.04.2012Full payment received (date of receipt of payment)
Request granted
24.04.2012Decision despatched
The application was refused due to failure to file the sequence listing
17.01.2008Request for further processing filed
17.01.2008Full payment received (date of receipt of payment)
Request granted
04.04.2008Decision despatched
Fees paidRenewal fee
06.08.2007Renewal fee patent year 03
06.08.2007Renewal fee patent year 04
06.08.2007Renewal fee patent year 05
06.08.2007Renewal fee patent year 06
06.08.2007Renewal fee patent year 07
06.08.2007Renewal fee patent year 08
06.08.2007Renewal fee patent year 09
06.08.2007Renewal fee patent year 10
06.08.2007Renewal fee patent year 11
06.08.2007Renewal fee patent year 12
09.06.2007Renewal fee patent year 13
12.12.2007Renewal fee patent year 14
31.03.2008Renewal fee patent year 15
11.12.2009Renewal fee patent year 16
15.12.2010Renewal fee patent year 17
12.12.2011Renewal fee patent year 18
11.12.2012Renewal fee patent year 19
12.12.2013Renewal fee patent year 20
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[A]WO9106626  (GILEAD SCIENCES INC [US]) [A] 1-25 * page 4 - page 5 * * example 8 *;
 [XY]WO9219732  (GENSET SA [FR]) [X] 21-23 * page 17 - page 18 * * page 24 - page 25 * * page 33; figures 1,5; claim - * [Y] 1-11;
 [A]WO9312230  (STANFORD RES INST INT [US]) [A] 1-25 * page 8, line 25 - line 31 * * page 28 - page 33 * * figures 12b,13; claims 19-23 *;
 [YD]FR2687411  (NICE SOPHIA ANTIPOLIS UNIVERSI [FR]) [YD] 1-11 * the whole document *;
 [X]  - ROBERTS R W ET AL, "STABILITY AND PROPERTIES OF DOUBLE AND TRIPLE HELICES: DRAMATIC EFFECTS OF RNA OR DNA BACKBONE COMPOSITION", SCIENCE, (19921127), vol. 258, ISSN 0036-8075, pages 1463 - 1466, XP002026847 [X] 1-4,7-10,12,19-22 * the whole document *

DOI:   http://dx.doi.org/10.1126/science.1279808
 [A]  - GIOVANNANGELI C ET AL, "OLIGONUCLEOTIDE CLAMPS ARREST DNA SYNTHESIS ON A SINGLE-STRANDED DNA TARGET", PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES, (199311), vol. 90, ISSN 0027-8424, pages 10013 - 10017, XP002007115 [A] 1-25 * the whole document *

DOI:   http://dx.doi.org/10.1073/pnas.90.21.10013
 [AD]  - GIOVANNANGELI C ET AL, "Single-stranded DNA as a target for triple-helix formation", JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, (1991), vol. 113, ISSN 0002-7863, pages 7775 - 7777, XP002089280 [AD] 1-25 * the whole document *

DOI:   http://dx.doi.org/10.1021/ja00020a058
 [A]  - MILLIGAN J F ET AL, "Oligoribonucleotide synthesis using T7 RNA polymerase and synthetic DNA templates", NUCLEIC ACIDS RESEARCH, (19871111), vol. 15, no. 21, ISSN 0305-1048, pages 8783 - 8798, XP002360370 [A] 1 * the whole document *
 [T]  - KANDIMALLA EKAMBAR R ET AL, "Single-strand-targeted triplex formation: Stability, specificity and RNase H activation properties", GENE, (1994), vol. 149, no. 1, ISSN 0378-1119, pages 115 - 121, XP002511320
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.